Literature DB >> 26757338

Supplemental Breast Cancer Screening in Women With Dense Breasts Should Be Offered With Simultaneous Collection of Outcomes Data.

Wendie A Berg.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26757338      PMCID： PMC4829104          DOI： 10.7326/M15-2977

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

1.  Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening.

Authors:  Sherry Yueh-Hsia Chiu; Stephen Duffy; Amy Ming-Fang Yen; Laszlo Tabár; Robert A Smith; Hsiu-Hsi Chen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-04-20       Impact factor: 4.254

Review 2.  Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force.

Authors:  Joy Melnikow; Joshua J Fenton; Evelyn P Whitlock; Diana L Miglioretti; Meghan S Weyrich; Jamie H Thompson; Kunal Shah
Journal:  Ann Intern Med       Date:  2016-01-12       Impact factor: 25.391

3.  Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC).

Authors:  Sepideh Saadatmand; Inge-Marie Obdeijn; Emiel J Rutgers; Jan C Oosterwijk; Rob A Tollenaar; Gwendolyn H Woldringh; Elisabeth Bergers; Cornelis Verhoef; Eveline A Heijnsdijk; Maartje J Hooning; Harry J de Koning; Madeleine M Tilanus-Linthorst
Journal:  Int J Cancer       Date:  2015-04-17       Impact factor: 7.396

4.  Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging.

Authors:  Ellen Warner; Kimberley Hill; Petrina Causer; Donald Plewes; Roberta Jong; Martin Yaffe; William D Foulkes; Parviz Ghadirian; Henry Lynch; Fergus Couch; John Wong; Frances Wright; Ping Sun; Steven A Narod
Journal:  J Clin Oncol       Date:  2011-03-28       Impact factor: 44.544

5.  Ultrasound as the Primary Screening Test for Breast Cancer: Analysis From ACRIN 6666.

Authors:  Wendie A Berg; Andriy I Bandos; Ellen B Mendelson; Daniel Lehrer; Roberta A Jong; Etta D Pisano
Journal:  J Natl Cancer Inst       Date:  2015-12-28       Impact factor: 13.506

6.  Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program.

Authors:  Per Skaane; Andriy I Bandos; Randi Gullien; Ellen B Eben; Ulrika Ekseth; Unni Haakenaasen; Mina Izadi; Ingvild N Jebsen; Gunnar Jahr; Mona Krager; Loren T Niklason; Solveig Hofvind; David Gur
Journal:  Radiology       Date:  2013-01-07       Impact factor: 11.105

7.  Insights from the breast cancer screening trials: how screening affects the natural history of breast cancer and implications for evaluating service screening programs.

Authors:  László Tabár; Amy Ming-Fang Yen; Wendy Yi-Ying Wu; Sam Li-Sheng Chen; Sherry Yueh-Hsia Chiu; Jean Ching-Yuan Fann; May Mei-Sheng Ku; Robert A Smith; Stephen W Duffy; Tony Hsiu-Hsi Chen
Journal:  Breast J       Date:  2014-11-20       Impact factor: 2.431

Review 8.  Mammographic density and breast cancer risk: current understanding and future prospects.

Authors:  Norman F Boyd; Lisa J Martin; Martin J Yaffe; Salomon Minkin
Journal:  Breast Cancer Res       Date:  2011-11-01       Impact factor: 6.466

9.  Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial.

Authors:  Noriaki Ohuchi; Akihiko Suzuki; Tomotaka Sobue; Masaaki Kawai; Seiichiro Yamamoto; Ying-Fang Zheng; Yoko Narikawa Shiono; Hiroshi Saito; Shinichi Kuriyama; Eriko Tohno; Tokiko Endo; Akira Fukao; Ichiro Tsuji; Takuhiro Yamaguchi; Yasuo Ohashi; Mamoru Fukuda; Takanori Ishida
Journal:  Lancet       Date:  2015-11-05       Impact factor: 79.321
  9 in total
  7 in total

1.  Factors associated with MRI detection of occult lesions in newly diagnosed breast cancers.

Authors:  Julie Wecsler; Young Ju Jeong; Akshara S Raghavendra; Wendy J Mack; Debasish Tripathy; Mary W Yamashita; Pulin A Sheth; Linda Hovanessian Larsen; Christy A Russell; Heather MacDonald; Stephen F Sener; Julie E Lang
Journal:  J Surg Oncol       Date:  2020-01-26       Impact factor: 3.454

2.  3D Supine Automated Ultrasound (SAUS, ABUS, ABVS) for Supplemental Screening Women with Dense Breasts.

Authors:  Alexander Mundinger
Journal:  J Breast Health       Date:  2016-04-01

3.  Racial/ethnic differences in supplemental imaging for breast cancer screening in women with dense breasts.

Authors:  Charlotte Ezratty; Suzanne Vang; Jordonna Brown; Laurie R Margolies; Lina Jandorf; Jenny J Lin
Journal:  Breast Cancer Res Treat       Date:  2020-05-11       Impact factor: 4.872

4.  Detecting mammographically occult cancer in women with dense breasts using deep convolutional neural network and Radon Cumulative Distribution Transform.

Authors:  Juhun Lee; Robert M Nishikawa
Journal:  J Med Imaging (Bellingham)       Date:  2019-12-24

5.  Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy.

Authors:  Nariya Cho; Wonshik Han; Boo-Kyung Han; Min Sun Bae; Eun Sook Ko; Seok Jin Nam; Eun Young Chae; Jong Won Lee; Sung Hun Kim; Bong Joo Kang; Byung Joo Song; Eun-Kyung Kim; Hee Jung Moon; Seung Il Kim; Sun Mi Kim; Eunyoung Kang; Yunhee Choi; Hak Hee Kim; Woo Kyung Moon
Journal:  JAMA Oncol       Date:  2017-11-01       Impact factor: 31.777

6.  Localized mammographic density is associated with interval cancer and large breast cancer: a nested case-control study.

Authors:  Fredrik Strand; Edward Azavedo; Roxanna Hellgren; Keith Humphreys; Mikael Eriksson; John Shepherd; Per Hall; Kamila Czene
Journal:  Breast Cancer Res       Date:  2019-01-22       Impact factor: 6.466

7.  Evaluation of the Pink Luminous Breast LED-Based Technology Device as a Screening Tool for the Early Detection of Breast Abnormalities.

Authors:  Fernando Ocasio-Villa; Luisa Morales-Torres; Norma Velez-Medina; Luis A Cubano; Juan C Orengo; Edu B Suarez Martinez
Journal:  Front Med (Lausanne)       Date:  2022-02-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.